INC Research Holdings, Inc. (SYNH)
(Delayed Data from NSDQ)
$47.27 USD
+0.56 (1.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $47.36 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$47.27 USD
+0.56 (1.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $47.36 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Bright Near-Term Outlook for Medical Info Systems Industry
by Sweta Jaiswal
The wave of digital transition is helping players in the Zacks Medical Info Systems industry to open up bountiful opportunities for investors.
Syneos Health (SYNH) Down 5.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Syneos Health (SYNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Syneos Health (SYNH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Syneos Health (SYNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SYNH vs. NXGN: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. NXGN: Which Stock Is the Better Value Option?
SYNH vs. CRL: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. CRL: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Gray Television, Syneos, Dollar General, Sabre and Jones Lang
by Zacks Equity Research
Zacks.com featured highlights include: Gray Television, Syneos, Dollar General, Sabre and Jones Lang
5 Cheap GARP Picks With Discounted PEG
by Zacks Equity Research
To make a long-term investment more effective, the principles of both value and growth strategies need to be combined.
Syneos Health (SYNH) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Syneos Health (SYNH) delivered earnings and revenue surprises of 10.29% and 0.44%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Syneos Health (SYNH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SYNH vs. FCHS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
SYNH or FCHS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
SYNH or FCHS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
PRA Health Sciences (PRAH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
PRA Health Sciences (PRAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SYNH or FCHS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
SYNH or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. HQY: Which Stock Is the Better Value Option?
Syneos Health (SYNH) Beats Q2 Earnings Estimates
by Zacks Equity Research
Syneos Health (SYNH) delivered earnings and revenue surprises of 3.33% and -0.98%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
SYNH or FCHS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
SYNH vs. FCHS: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
Syneos Health (SYNH): Moving Average Crossover Alert
by Zacks Equity Research
Syneos Health, Inc. (SYNH) is looking like an interesting pick from a technical perspective
SYNH vs. FCHS: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. FCHS: Which Stock Is the Better Value Option?
Syneos Health (SYNH) Shares March Higher, Can It Continue?
by Zacks Equity Research
Syneos Health, Inc. (SYNH) has been on the move lately as the stock has risen by 18.9% in the past four weeks, and it is currently trading well above its 20-Day SMA
Envision Healthcare to Go Private With Acquisition by KKR
by Zacks Equity Research
Envision Healthcare to become a private company on acquisition by private equity company KKR.
SYNH vs. HQY: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. HQY: Which Stock Is the Better Value Option?